Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations

Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma Inc., sold 986 shares of common stock on November 1, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On November 1, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 986 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
• The shares were sold at a price of $0.8.
• Following the transaction, Chakraborty directly owns 170,810 shares of Vor Biopharma Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing relates to a routine transaction for tax purposes and doesn't indicate any fundamental change in the company's prospects.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction appears to be a standard sale to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by an officer may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial condition.

Key Dates